Cardiac contractility modulation (CCM) is an innovative device-based therapy designed to enhance myocardial performance in patients with heart failure, particularly those with reduced ejection ...

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5 Receive the the latest news, research, and presentations from ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

Heart disease is expected to spike over the next 25 years among younger women, according to a new warning from the American Heart Association. Doctors at Jefferson Einstein Hospital are now using an ...

The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...

JONESBORO, Ark. (KAIT) - One Northeast Arkansas hospital became the first in the state to successfully implant a new heart failure device. NEA Baptist announced they successfully implanted a Cardiac ...

Please provide your email address to receive an email when new articles are posted on . The Integra-D trial evaluated a novel implantable cardiac contractility modulation defibrillator for its ability ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a draft coverage memo for cardiac contractility modulation (CCM), which offers coverage with evidence development for the company’s ...

Systemic arterial hypertension is accompanied by autonomic impairments that, if not contained, promotes cardiac functional and morphological damages. Pyridostigmine bromide (PYR) treatment results in ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...